Brivudine
Brivudine is used in the treatment of herpes zoster. Although not approved in the U.S. or Canada, it is approved in several European countries.
Systematic Name
5-[(1E)-2-bromoethenyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
Brand Name(S)
Zostex, Mevir, Brivir
Therapeutic Category
Anti-viral
Suitable Formulations
Solid
Approvals
US DMF*, EU ASMF
EU-WC
